Theodore Ashburn

Theodore Ashburn

Net worth: 12 518 $ as of 2023-12-30

57 year
Health Technology
Consumer Services
Finance

Profile

Theodore T.
Ashburn
is the founder of BrainCells, Inc., Dynogen Pharmaceuticals, Inc. He worked as the Chairman of Oncorus, Inc. and held senior positions at Dicerna Pharmaceuticals, Inc., Moderna, Inc., Sanofi Oncology, and Leukine.
Ashburn received his undergraduate degree from Ball State University and doctorates from Massachusetts Institute of Technology and Harvard Medical School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-03-30 99,352 ( 0.38% ) 12 518 $ 2023-12-30

Former positions of Theodore Ashburn

CompaniesPositionEnd
ONCORUS, INC. Chief Executive Officer 2023-06-05
MODERNA, INC. Corporate Officer/Principal 2018-06-30
Founder 2009-11-12
Corporate Officer/Principal -
Leukine Corporate Officer/Principal -
See the detail of Theodore Ashburn's experience

Training of Theodore Ashburn

Ball State University (Indiana) Undergraduate Degree
Massachusetts Institute of Technology Doctorate Degree
Harvard Medical School Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Theodore Ashburn's experience

Connections

32

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
ONCORUS, INC.

Health Technology

MODERNA, INC.

Health Technology

Private companies5

Health Technology

Health Technology

Health Technology

Commercial Services

Leukine

See company connections
  1. Stock Market
  2. Insiders
  3. Theodore Ashburn